Clinical

临床

• 批准号: 8292625
• 负责人: RICHARD Douglas MOORE
• 金额: $ 46.66万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-05-02 至 2017-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8292625
• 关键词: Acquired Immunodeficiency Syndrome; Applications Grants; Award; Baltimore; Cardiovascular Diseases; Cardiovascular system; Clinical; Clinical Research; Clinical Treatment; Collaborations; Communities; Comorbidity; Development; Discipline; Disease; Endocrine; Environment; Feedback; Fostering; Foundations; Funding; Generations; Geriatrics; Goals; HIV; Hepatitis; Hepatitis B; Hepatitis B Virus; Hepatitis C; Hepatitis C virus; Human Subject Research; Incubated; Individual; Infection; Inflammation; Institutional Review Boards; International; Kidney; Kidney Diseases; Libraries; Malaria; Malignant Neoplasms; Measures; Metabolic; Methodology; Morbidity - disease rate; Neurocognitive; Online Systems; Patient Care; Patients; Peer Review; Peripheral Nervous System Diseases; Pilot Projects; Population; Process; Public Health Nurses; Public Health Nursing; Research; Research Activity; Research Infrastructure; Research Methodology; Research Personnel; Research Support; Resources; Science; Series; Services; Substance abuse problem; Testing; Translational Research; Tuberculosis; Universities; Viral; Viral hepatitis; Work; career; clinical conference; evidence base; experience; implementation science; improved; innovation; mathematical model; medical schools; meetings; mortality; multidisciplinary; next generation; novel; novel strategies; patient oriented; patient population; programs; tool; working group

The Clinical Core will provide strategic direction and infrastructure to increase patient-oriented collaborative clinical and translafional research by the JHU investigative community. We will focus our scientific agenda on the treatment and clinical progression of HlV-infection and associated opportunistic illness, important co-infecfions (TB, viral hepatifis, etc.) and on emerging non-infecfious co-morbidifies (cardiovascular, kidney, endocrine/metabolic, neurocognitive, and malignancy) and substance abuse.

临床核心将提供战略方向和基础设施，以增加以患者为导向的 JHU调查社区的合作临床和翻译研究。我们将集中精力 关于HLV感染和相关机会主义的治疗和临床进展的科学议程 疾病，重要的共同侵犯（结核病，病毒肝等）以及新兴的非迷恋合并症 （心血管，肾脏，内分泌/代谢，神经认知和恶性肿瘤）和药物滥用。